Education on chemotherapy side effects via social media for breast cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate whether a standardized education module provided by pharmacists through social media can enhance breast cancer patients' understanding of chemotherapy-related side effects. Participants will be randomly assigned to receive either video education or traditional handouts during their first chemotherapy session. The study will assess knowledge improvement through pre- and post-education questionnaires. The educational content includes information on side effects, prevention strategies, and when to seek medical help.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Breast cancer patients aged 18 or older undergoing their first chemotherapy.
* Possess a smartphone and are able to watch videos on it.

Exclusion Criteria:

* Unable to read or complete questionnaires in Chinese.
* Cognitive impairments.
* Pregnant women.

Where it's running

• Shuang Ho Hospital
  New Taipei City, Taiwan Recruiting

Study contacts

• Principal investigator: Pohung Lin, PharmD — Taipei Medical University Shuang Ho Hospital
• Study coordinator: Pohung Lin, PharmD
• Email: 19365@s.tmu.edu.tw
• Phone: 886-933-826-267

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-powered mobile app to help breast cancer patients manage chemotherapy symptoms

  A mobile app with artificial intelligence is being tested to see if it helps women with breast cancer manage chemotherapy symptoms and feel more confident in their care.

  Recruiting Ege University · Izmir, İzmir · NCT07826338

• Dental social media communication: what legal and ethical rules apply

  This project tests whether dentists, other health professionals, and patients in Italy understand and follow the legal and ethical rules for dental communication on social media.

  Recruiting University of Roma La Sapienza · Roma, RM · NCT07550153

• DA-020 topically for chemotherapy-induced hair loss

  This study tests DA-020 (a topical alpha-1 agonist) to see if it can reduce hair loss in people with breast cancer receiving certain chemotherapies.

  Recruiting Phase 1/2 Applied Biology, Inc. · Manaus and 1 other locations · NCT07397325

• Social media, food cravings, and ultra-processed food habits in university students

  This study will test whether seeing ultra-processed food content on social media increases food cravings and consumption among university students aged 18–25 in Ankara.

  Recruiting Atılım University · Ankara · NCT07103811

• Comparing total neoadjuvant therapy with surgery for rectal cancer treatment

  This study is testing if rectal cancer patients who respond well to a new treatment can skip surgery and just be monitored to see how they do compared to those who have surgery right away.

  Recruiting Phase 2/3 National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos · Vilnius · NCT06758830

• Remote physical activity program for cancer survivors with and without diabetes

  This study is trying out a remote exercise program for cancer survivors, with and without diabetes, to see if it can help improve their quality of life and cognitive skills after chemotherapy.

  Recruiting University of Oklahoma · Oklahoma City, Oklahoma · NCT06725953

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.